S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NYSE:CVS

CVS Health Stock Forecast, Price & News

$74.12
+0.04 (+0.05 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$73.02
Now: $74.12
$74.30
50-Day Range
$67.22
MA: $71.82
$76.26
52-Week Range
$52.04
Now: $74.12
$77.23
Volume4.18 million shs
Average Volume7.17 million shs
Market Capitalization$97.02 billion
P/E Ratio12.25
Dividend Yield2.70%
Beta0.82
CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans (PDPs), Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. The company was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
CVS Health logo

MarketRank

Overall MarketRank

2.54 out of 5 stars

Retail/Wholesale Sector

4th out of 383 stocks

Drug Stores & Proprietary Stores Industry

1st out of 14 stocks

Analyst Opinion: 3.4Community Rank: 3.2Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
CUSIP12665010
Phone401-765-1500
Employees290,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$256.78 billion
Cash Flow$10.17 per share
Book Value$49.33 per share

Profitability

Net Income$6.63 billion

Miscellaneous

Outstanding Shares1,308,914,000
Market Cap$97.02 billion
Next Earnings Date2/10/2021 (Estimated)
OptionableOptionable
$74.12
+0.04 (+0.05 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CVS Health (NYSE:CVS) Frequently Asked Questions

How has CVS Health's stock been impacted by Coronavirus (COVID-19)?

CVS Health's stock was trading at $61.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CVS stock has increased by 20.9% and is now trading at $74.12.
View which stocks have been most impacted by COVID-19
.

Is CVS Health a buy right now?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last twelve months. There are currently 3 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CVS Health stock.
View analyst ratings for CVS Health
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than CVS Health?

Wall Street analysts have given CVS Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CVS Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as CVS Health's CEO?

6,978 employees have rated CVS Health CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among CVS Health's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is CVS Health's next earnings date?

CVS Health is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021.
View our earnings forecast for CVS Health
.

How were CVS Health's earnings last quarter?

CVS Health Co. (NYSE:CVS) posted its quarterly earnings results on Wednesday, November, 11th. The pharmacy operator reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.33. The pharmacy operator earned $67.05 billion during the quarter, compared to analyst estimates of $66.54 billion. CVS Health had a net margin of 2.99% and a trailing twelve-month return on equity of 15.60%. The business's quarterly revenue was up 3.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.84 EPS.
View CVS Health's earnings history
.

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Monday, January 4th. Shareholders of record on Friday, January 22nd will be given a dividend of $0.50 per share on Monday, February 1st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date is Thursday, January 21st.
View CVS Health's dividend history
.

Is CVS Health a good dividend stock?

CVS Health pays an annual dividend of $2.00 per share and currently has a dividend yield of 2.70%. CVS Health does not yet have a strock track record of dividend growth. The dividend payout ratio of CVS Health is 28.25%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CVS Health will have a dividend payout ratio of 26.56% next year. This indicates that CVS Health will be able to sustain or increase its dividend.
View CVS Health's dividend history.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY20 earnings guidance on Friday, November, 6th. The company provided EPS guidance of $7.35-7.42 for the period, compared to the Thomson Reuters consensus estimate of $7.23.

What price target have analysts set for CVS?

16 Wall Street analysts have issued 12 month price targets for CVS Health's shares. Their forecasts range from $66.00 to $101.00. On average, they expect CVS Health's stock price to reach $82.93 in the next year. This suggests a possible upside of 11.9% from the stock's current price.
View analysts' price targets for CVS Health
or view Wall Street analyst' top-rated stocks.

Who are some of CVS Health's key competitors?

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), The Walt Disney (DIS), Johnson & Johnson (JNJ), NVIDIA (NVDA), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA) and The Home Depot (HD).

Who are CVS Health's key executives?

CVS Health's management team includes the following people:
  • Mr. Larry J. Merlo, Pres, CEO & Director (Age 65, Pay $12.83M)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 54, Pay $4.56M)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 65, Pay $7.55M)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 57, Pay $5.78M)
  • Mr. James David Clark, Sr. VP, Controller & Chief Accounting Officer (Age 56)
  • Ms. Valerie C. Haertel, Sr. VP of Investor Relations
  • Mr. David A. Falkowski, Exec. VP & Chief Compliance Officer
  • Ms. Lisa G. Bisaccia, Exec. VP & Chief HR Officer (Age 65)
  • Mr. Troyen A. Brennan M.D., M.P.H., J.D., Exec. VP & Chief Medical Officer (Age 66)
  • Mr. Joshua Matthew Flum, Exec. VP of Enterprise Strategy & Digital (Age 51)

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Scharf Investments LLC (0.15%), Focused Investors LLC (0.06%), RNC Capital Management LLC (0.05%), Gateway Investment Advisers LLC (0.04%), Douglas Lane & Associates LLC (0.04%) and Gillespie Robinson & Grimm Inc. (0.03%). Company insiders that own CVS Health stock include Alan Lotvin, C David Brown II, David W Dorman, Edward J Ludwig, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Karen S Lynch, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin.
View institutional ownership trends for CVS Health
.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Avantax Advisory Services Inc., Windward Capital Management Co. CA, Gateway Investment Advisers LLC, RNC Capital Management LLC, Cohen Klingenstein LLC, Pacer Advisors Inc., and Pacifica Partners Inc.. Company insiders that have sold CVS Health company stock in the last year include Alan Lotvin, James David Clark, Larry J Merlo, and Lisa Bisaccia.
View insider buying and selling activity for CVS Health
or view top insider-selling stocks.

Which institutional investors are buying CVS Health stock?

CVS stock was acquired by a variety of institutional investors in the last quarter, including Scharf Investments LLC, Cadinha & Co. LLC, Rhenman & Partners Asset Management AB, Kestra Advisory Services LLC, Nepsis Inc., Candriam Luxembourg S.C.A., Signature Wealth Management Group, and Douglas Lane & Associates LLC. Company insiders that have bought CVS Health stock in the last two years include Alan Lotvin, C David Brown II, David W Dorman, and Edward J Ludwig.
View insider buying and selling activity for CVS Health
or or view top insider-buying stocks.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $74.12.

How big of a company is CVS Health?

CVS Health has a market capitalization of $97.02 billion and generates $256.78 billion in revenue each year. The pharmacy operator earns $6.63 billion in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 290,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.